Literature DB >> 638575

Plasmapheresis.

.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 638575      PMCID： PMC1604012     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  14 in total

1.  Goodpasture syndrome treated with immunosuppression and plasma exchange.

Authors:  C H Lang; D C Brown; N Staley; G Johnson; K W Ma; W A Border; A P Dalmasso
Journal:  Arch Intern Med       Date:  1977-08

2.  Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.

Authors:  P C Dau; J M Lindstrom; C K Cassel; E H Denys; E E Shev; L E Spitler
Journal:  N Engl J Med       Date:  1977-11-24       Impact factor: 91.245

3.  Safety and long-term effects of plasmapheresis.

Authors:  M A Cohen; H A Oberman
Journal:  Transfusion       Date:  1970 Mar-Apr       Impact factor: 3.157

4.  Intensive plasmapheresis as a therapeutic measure in Rhesus-immunised women.

Authors:  C A Clarke; C J Elson; J Bradley; W T Donohoe; D Lehane; N C Hughes-Jones
Journal:  Lancet       Date:  1970-04-18       Impact factor: 79.321

5.  Plasma exchange in myasthenia gravis.

Authors:  R Finn; P M Coates
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

6.  [Plasmapheresis for myasthenia gravis].

Authors:  J Newsom-Davis; A Vincent; S G Wilson; C D Ward; A J Pinching; C Hawkey
Journal:  N Engl J Med       Date:  1978-02-23       Impact factor: 91.245

7.  Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome.

Authors:  C M Lockwood; A J Rees; T A Pearson; D J Evans; D K Peters; C B Wilson
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321

8.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

9.  Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.

Authors:  K V Toyka; D B Drachman; D E Griffin; A Pestronk; J A Winkelstein; K H Fishbeck; I Kao
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

10.  Remission of myasthenia gravis following plasma-exchange.

Authors:  A J Pinching; D K Peters
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.